Search Results - "BILLINGS, LIANA"

The genetics of type 2 diabetes: what have we learned from GWAS? by Billings, Liana K., Florez, Jose C.

“…Type 2 diabetes mellitus has been at the forefront of human diseases and phenotypes studied by new genetic analyses. Thanks to genome‐wide association studies,…”
Get full text

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial by Billings, Liana K, Doshi, Ankur, Gouet, Didier, Oviedo, Alejandra, Rodbard, Helena W, Tentolouris, Nikolaos, Grøn, Randi, Halladin, Natalie, Jodar, Esteban

“…In patients with uncontrolled type 2 diabetes on basal insulin, prandial insulin may be initiated. We assessed the efficacy and safety of initiating insulin…”
Get full text

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial by Wadden, Thomas A, Bailey, Timothy S, Billings, Liana K, Davies, Melanie, Frias, Juan P, Koroleva, Anna, Lingvay, Ildiko, O’Neil, Patrick M, Rubino, Domenica M, Skovgaard, Dorthe, Wallenstein, Signe O. R, Garvey, W. Timothy

“…IMPORTANCE: Weight loss improves cardiometabolic risk factors in people with overweight or obesity. Intensive lifestyle intervention and pharmacotherapy are…”
Get full text

GLP-1 RA and SGLT2 Inhibitors: In Harmony for Organ Protection by Aroda, Vanita R., Billings, Liana K.

“…[Display omitted]…”
Get full text

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes by Mehta, Roopa, Billings, Liana K., Liebl, Andreas, Vilsbøll, Tina

“…Aims Two fixed‐ratio combinations (FRCs) of basal insulin and glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) are available for once‐daily use in adults…”
Get full text

Leveraging advances in diabetes technologies in primary care: a narrative review by Bode, Bruce, King, Aaron, Russell-Jones, David, Billings, Liana K.

“…Primary care providers (PCPs) play an important role in providing medical care for patients with type 2 diabetes. Advancements in diabetes technologies can…”
Get full text

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program by Billings, Liana K, Parkin, Christopher G, Price, David

“…The DIAMOND study demonstrated that the addition of real-time continuous glucose monitoring (rtCGM) effectively lowers glycated hemoglobin (HbA ) in patients…”
Get more information

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study by Rossing, Peter, Anker, Stefan D., Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M., Billings, Liana K., Green, Jennifer B., Koya, Daisuke, Mosenzon, Ofri, Pantalone, Kevin M., Ahlers, Christiane, Lage, Andrea, Lawatscheck, Robert, Scalise, Andrea, Bakris, George L.

“…Aim To assess the effect of finerenone on the risk of cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes, with and…”
Get full text

689-P: Association of Preoperative Glycemic Response to GLP-1 Receptor Agonists (GLP-1RA) and Outcomes of Bariatric Surgery by AMUSIN, DANIEL, KUCHTA, KRISTINE, EWING, TATUM, TUCKER, LYNN, CAMPBELL, MICHELLE, UJIKI, MICHAEL, BILLINGS, LIANA K.

“…Background: GLP1RAs are an increasingly common treatment in the setting of type 2 diabetes mellitus (T2DM). One hypothesized mechanism by which bariatric…”
Get full text

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes by Philis‐Tsimikas, Athena, Billings, Liana K., Busch, Robert, Portillo, Cristobal Morales, Sahay, Rakesh, Halladin, Natalie, Eggert, Sarah, Begtrup, Kamilla, Harris, Stewart

“…Aim To investigate the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as add‐on to…”
Get full text

Effect of a Type 2 Diabetes-Focused Visit Improvement Initiative on Therapeutic Inertia and Glycemic Control in Primary Care by Oshman, Lauren, Biszewski, Matthew, Carlock, Francesca, Radz, Marcus, Neu, Rachel, Billings, Liana K

“…Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the…”
Get full text

Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes by Billings, Liana K, Shi, Zhuqing, Wei, Jun, Rifkin, Andrew S, Zheng, S Lilly, Helfand, Brian T, Ilbawi, Nadim, Dunnenberger, Henry M, Hulick, Peter J, Qamar, Arman, Xu, Jianfeng

“…Abstract Context Misclassification of diabetes type occurs in people with atypical presentations of type 1 diabetes (T1D) or type 2 diabetes (T2D). Although…”
Get full text

Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes by Philis-Tsimikas, Athena, Aroda, Vanita R., De Block, Christophe, Billings, Liana K., Liebl, Andreas, Sivarathinasami, Ramsathish, D’Cruz, John M., Lingvay, Ildiko

“…Background: Derived time in range (dTIR), calculated from self-monitored blood glucose (SMBG-dTIR) profiles, has demonstrated correlation with risk of…”
Get full text

Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective by Nicholas, Susanne B., Wright, Eugene E., Billings, Liana K., Ambriz, Estela, Gee, Patrick, Peeler, Terry

“…Comorbid type 2 diabetes mellitus (T2D) and chronic kidney disease (CKD) is associated with poor health outcomes and a high economic burden. Management of…”
Get full text

Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With Prediabetes by Billings, Liana K, Jablonski, Kathleen A, Pan, Qing, Florez, Jose C, Franks, Paul W, Goldberg, Ronald B, Hivert, Marie-France, Kahn, Steven E, Knowler, William C, Lee, Christine G, Merino, Jordi, Huerta-Chagoya, Alicia, Mercader, Josep M, Raghavan, Sridharan, Shi, Zhuqing, Srinivasan, Shylaja, Xu, Jianfeng, Udler, Miriam S

“…Partitioned polygenic scores (pPS) have been developed to capture pathophysiologic processes underlying type 2 diabetes (T2D). We investigated the association…”
Get full text

1687-P: An Examination of Clinical Outcomes in People with T1D and Obesity by STEWART, EMMA R., MONIE, ALLISON M., BILLINGS, LIANA K.

“…A lack of knowledge exists concerning how best to treat type 1 diabetes (T1D) and obesity simultaneously. This cross-sectional study examined whether people…”
Get full text

Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects by Lim, Soo, Kim, Min Joo, Choi, Sung Hee, Shin, Chan Soo, Park, Kyong Soo, Jang, Hak Chul, Billings, Liana K, Meigs, James B

“…Background: Recent studies suggest an association between 25-hydroxyvitamin D [25(OH)D] and type 2 diabetes (T2D) risk. However, prospective studies…”
Get full text

Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus by Billings, Liana K, Handelsman, Yehuda, Heile, Michael, Schneider, Doron, Wyne, Kathleen

“…Type 2 diabetes (T2DM) is associated with significant impairment in health-related quality of life (HRQoL). A patient-centered collaborative approach is…”
Get full text

Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia by Goldenberg, Ronald M., Aroda, Vanita R., Billings, Liana K., Christiansen, A. Sia Louise, Meller Donatsky, Anders, Parvaresh Rizi, Ehsan, Podgorski, Gracjan, Raslova, Katarina, Klonoff, David C., Bergenstal, Richard M.

“…Aims To compare time in range (TIR) with use of insulin degludec U100 (degludec) versus insulin glargine U100 (glargine U100) in people with type 2 diabetes…”
Get full text

618-P: Association between Time-in-Range and A1C in Basal Insulin-Treated People with Type 2 Diabetes by GOLDENBERG, RONALD, ARODA, VANITA R., BILLINGS, LIANA K., DONATSKY, ANDERS MELLER, FREDERIKSEN, MARIE, KLONOFF, DAVID C., RIZI, EHSAN PARVARESH, BERGENSTAL, RICHARD M.

“…Background: The randomized, crossover SWITCH PRO trial demonstrated increased time in range (TIR) with insulin degludec vs. insulin glargine U100 in basal…”
Get full text